Menu
Recruiting NCT07056244

Dexmedetomidine Versus Dexamethasone as Adjuvants to Bupivacaine in Caudal Epidural Block

No phase Interventional İnguinal Hernia

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Dexmedetomidine, Dexamethasone.
Who it may be relevant to
Registry conditions: İnguinal Hernia. Basic parameters: 2 years — 6 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Dexmedetomidine Versus Dexamethasone as Adjuvants to Bupivacaine in Caudal Epidural Block for Pediatrics Undergoing Inguinal Hernia Surgery: A Comparative Prospective Double-Blind Randomized Clinical Trial

Overview

The goal of This prospective, randomized, double-blind comparative study is to compare the efficacy of dexamethasone and dexmedetomidine as adjuvants to bupivacaine 0.125% in caudal epidural block for pediatrics undergoing inguinal hernia surgery, aged 2-6 years. of Both sex.

Interventions

  • Drug Dexmedetomidine
    as adjuvant to bupivacaine in caudal epidural block for postoperative analgesia
  • Drug Dexamethasone
    as adjuvant to bupivacaine in caudal epidural block for postoperative analgesia

Primary outcome measures

  • duration of postoperative analgesia [Time frame: "Pain scores will be assessed at 15-minute intervals during the first two hours postoperatively, then at 4, 6, 8,12 and 24 hour"]
Secondary outcome measures (1)
  • Pain score [Time frame: "Pain scores will be assessed at 15-minute intervals during the first two hours postoperatively, then at 4, 6, 8,12 and 24 hour"]

Eligibility criteria

Inclusion criteria

  • Children aged 2-6 years.
  • Both sexes.
  • American Society of Anesthesiologists (ASA) physical status I and II.
  • Scheduled for inguinal hernia surgery

Exclusion criteria

  • Parents or legal guardians refusal.
  • Known hypersensitivity to any study drugs.
  • Abnormal sacral anatomy
  • Local infection at the injection site.
  • Neurological disease.
  • Coagulopathy.
  • Mental retardation.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Other

Study locations

Egypt · 1 center
  • Sohag university Hospital — Sohag

Identifiers

NCT: NCT07056244 · soh-Med-25-6-13MS

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗